van't Veer L - Search Results

1

Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.

Locasciulli A, van't Veer L, Bacigalupo A, Hows J, Van Lint MT, Gluckman E, Nissen C, McCann S, Vossen J, Schrezenmeier A, et al. Locasciulli A, et al. Bone Marrow Transplant. 1990 Sep;6(3):211-7. Bone Marrow Transplant. 1990. PMID: 2252962

2

Bone marrow transplantation (BMT) in children with severe aplastic anemia (SAA) from donors other than HLA identical siblings. EBMT Working Party on Severe Aplastic Anemia.

Locasciulli A, van' t Veer L, Hows J, Van Lint MT, Gluckman E, Nissen C, McCann S, Vossen J, Schrezenmeier A, Hinterberger W, et al. Locasciulli A, et al. Bone Marrow Transplant. 1991;7 Suppl 3:90-1. Bone Marrow Transplant. 1991. PMID: 1855098 No abstract available.

3

Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children.

Locasciulli A, Vossen J, Bacigalupo A, Hows J, VanLint MT, Gluckman E, Nissen C, McCann S, de Planque M, van'tVeer L, et al. Locasciulli A, et al. Bone Marrow Transplant. 1989 Dec;4 Suppl 4:123-5. Bone Marrow Transplant. 1989. PMID: 2697423 Clinical Trial.

4

70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.

Piccart M, van 't Veer LJ, Poncet C, Lopes Cardozo JMN, Delaloge S, Pierga JY, Vuylsteke P, Brain E, Vrijaldenhoven S, Neijenhuis PA, Causeret S, Smilde TJ, Viale G, Glas AM, Delorenzi M, Sotiriou C, Rubio IT, Kümmel S, Zoppoli G, Thompson AM, Matos E, Zaman K, Hilbers F, Fumagalli D, Ravdin P, Knox S, Tryfonidis K, Peric A, Meulemans B, Bogaerts J, Cardoso F, Rutgers EJT. Piccart M, et al. Lancet Oncol. 2021 Apr;22(4):476-488. doi: 10.1016/S1470-2045(21)00007-3. Epub 2021 Mar 12. Lancet Oncol. 2021. PMID: 33721561 Clinical Trial.

5

Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial.

Bogaerts J, Cardoso F, Buyse M, Braga S, Loi S, Harrison JA, Bines J, Mook S, Decker N, Ravdin P, Therasse P, Rutgers E, van 't Veer LJ, Piccart M; TRANSBIG consortium. Bogaerts J, et al. Nat Clin Pract Oncol. 2006 Oct;3(10):540-51. doi: 10.1038/ncponc0591. Nat Clin Pract Oncol. 2006. PMID: 17019432 Review.

6

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial.

Viale G, de Snoo FA, Slaets L, Bogaerts J, van 't Veer L, Rutgers EJ, Piccart-Gebhart MJ, Stork-Sloots L, Glas A, Russo L, Dell'Orto P, Tryfonidis K, Litière S, Cardoso F; MINDACT investigators. Viale G, et al. Breast Cancer Res Treat. 2018 Jan;167(1):123-131. doi: 10.1007/s10549-017-4509-9. Epub 2017 Sep 19. Breast Cancer Res Treat. 2018. PMID: 28929359 Clinical Trial.

7

Individualization of therapy using Mammaprint: from development to the MINDACT Trial.

Mook S, Van't Veer LJ, Rutgers EJ, Piccart-Gebhart MJ, Cardoso F. Mook S, et al. Cancer Genomics Proteomics. 2007 May-Jun;4(3):147-55. Cancer Genomics Proteomics. 2007. PMID: 17878518 Free article. Review.

8

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

Cardoso F, van't Veer LJ, Bogaerts J, Slaets L, Viale G, Delaloge S, Pierga JY, Brain E, Causeret S, DeLorenzi M, Glas AM, Golfinopoulos V, Goulioti T, Knox S, Matos E, Meulemans B, Neijenhuis PA, Nitz U, Passalacqua R, Ravdin P, Rubio IT, Saghatchian M, Smilde TJ, Sotiriou C, Stork L, Straehle C, Thomas G, Thompson AM, van der Hoeven JM, Vuylsteke P, Bernards R, Tryfonidis K, Rutgers E, Piccart M; MINDACT Investigators. Cardoso F, et al. N Engl J Med. 2016 Aug 25;375(8):717-29. doi: 10.1056/NEJMoa1602253. N Engl J Med. 2016. PMID: 27557300 Free article. Clinical Trial.

9

70-Gene Signature in Early-Stage Breast Cancer.

van’t Veer LJ, Rutgers EJT, Piccart M. van’t Veer LJ, et al. N Engl J Med. 2016 Dec 1;375(22):2200-2201. doi: 10.1056/NEJMc1612048. N Engl J Med. 2016. PMID: 27959762 No abstract available.

10

Controlling technical variation amongst 6693 patient microarrays of the randomized MINDACT trial.

Jacob L, Witteveen A, Beumer I, Delahaye L, Wehkamp D, van den Akker J, Snel M, Chan B, Floore A, Bakx N, Brink G, Poncet C, Bogaerts J, Delorenzi M, Piccart M, Rutgers E, Cardoso F, Speed T, van 't Veer L, Glas A. Jacob L, et al. Commun Biol. 2020 Jul 27;3(1):397. doi: 10.1038/s42003-020-1111-1. Commun Biol. 2020. PMID: 32719399 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters